28167 | TEST | testuser | 01/18/2016 3:17:09 AM |
28166 | dsfdfsdfsdf | testuser | 01/16/2016 1:06:56 PM |
28165 | This is a test | testuser | 01/16/2016 2:47:10 AM |
28164 | dasdsdasdads | testuser | 01/15/2016 9:29:36 AM |
28163 | sadasdasdsad | testuser | 01/15/2016 9:29:22 AM |
28162 | asdssadsd | testuser | 01/15/2016 9:28:44 AM |
28161 | dsfsdfdsfsdfsfs | testuser | 01/15/2016 9:05:53 AM |
28160 | dsfsdfsdfsdffsdfsdf | testuser | 01/15/2016 9:05:46 AM |
28159 | sdfsfdsfs fsd f sf | testuser | 01/15/2016 9:05:37 AM |
28158 | zfdsfdsfsddfdfs df | testuser | 01/15/2016 9:05:27 AM |
28157 | xdgdd sd fg | testuser | 01/15/2016 9:05:14 AM |
28156 | Djajajshshshshs | testuser | 01/15/2016 1:34:39 AM |
28155 | 5555555555 | testuser | 01/15/2016 1:33:31 AM |
28154 | 44444444444 | testuser | 01/15/2016 1:33:23 AM |
28153 | 33333 | testuser | 01/15/2016 1:33:15 AM |
28152 | 2222221312 | testuser | 01/15/2016 1:33:07 AM |
28151 | cxgcxbcxg | testuser | 01/15/2016 1:32:59 AM |
28150 | Got it, Good idea! | fitzkarz | 01/14/2016 9:19:37 PM |
28149 | Yes!! You fully control who can use/view | testuser | 01/14/2016 7:15:52 PM |
28148 | OK thats great. So I or anyone could create a | INSTATRADER | 01/14/2016 7:07:04 PM |
28147 | That is for all members | testuser | 01/14/2016 6:56:54 PM |
28146 | Would that only apply to paid members? That | INSTATRADER | 01/14/2016 3:39:44 PM |
28145 | post 4 | testuser | 01/14/2016 1:51:28 PM |
28141 | INSTATRADER, Have you had a chance to see our | testuser | 01/14/2016 1:24:56 PM |
28140 | A group PM would be people who want to be in your | INSTATRADER | 01/14/2016 1:20:51 PM |
28139 | That might be considered | fitzkarz | 01/14/2016 1:12:52 PM |
28138 | Try this link: | testdemo | 01/14/2016 10:43:19 AM |
28137 | vcb vcvcb vbvbvcb | testdemo | 01/14/2016 9:48:04 AM |
28136 | fx x fx bdfbd | testdemo | 01/14/2016 9:46:03 AM |
28135 | fdgfdx gfd | testdemo | 01/14/2016 9:45:55 AM |
28134 | fdgdfbgcxvfb vcxbvc | testdemo | 01/14/2016 9:45:44 AM |
28133 | fg fdgdg | testdemo | 01/14/2016 9:45:34 AM |
28132 | {yt}0RLoNRmvT3Q{yt} | testuser | 01/14/2016 8:56:35 AM |
28131 | 0RLoNRmvT3Q | testuser | 01/14/2016 8:39:29 AM |
28130 | _CG9MCclbAs | itest | 01/14/2016 7:15:57 AM |
28129 | fgdhfhf | testdemo | 01/13/2016 11:36:14 PM |
28128 | hfgjhgkghk | testdemo | 01/13/2016 11:35:24 PM |
28127 | hfghfg gdfhdd | testdemo | 01/13/2016 11:35:01 PM |
28126 | ghgdndfgj hfjfgkghk | testdemo | 01/13/2016 11:34:36 PM |
28125 | ffgegdgdf | testdemo | 01/13/2016 11:33:54 PM |
28124 | ddsdsdsdsdsds | testdemo | 01/13/2016 10:55:33 PM |
28123 | testing | testdemo | 01/13/2016 10:54:27 PM |
28122 | dffddfdf | testdemo | 01/13/2016 10:53:48 PM |
28121 | Regular post test link: | testuser | 01/13/2016 4:35:40 PM |
28120 | 5555555555555555 | testdemo | 01/13/2016 9:23:01 AM |
28119 | 444444444444 | testdemo | 01/13/2016 9:22:53 AM |
28118 | 3333333333333 | testdemo | 01/13/2016 9:22:46 AM |
28117 | fdgxfvcxvfdgrfdg | testdemo | 01/13/2016 9:22:36 AM |
28116 | fdgdfsgdsfsf | testdemo | 01/13/2016 9:22:22 AM |
28115 | tyryrru dydfjd | testdemo | 01/13/2016 12:13:38 AM |
Recent Articles
- Leslie's Performance in Q4: Key Insights and Future Prospects
- Exploring Central Garden & Pet's Recent Earnings Performance
- Insights into Enanta Pharma's Q4 Earnings Performance
- Blue Bird's Q4 Earnings Report Reveals Key Insights
- NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
- Columbia Financial Appoints Matthew Smith as New COO
- Impact of Treasury Picks on Markets and Emerging Economies
- Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
- Zoom Communications Enhances Forecast Following Strong Q3 Results
- Leadership Transition at Kohl's: Kingsbury's Departure Announced
- Tempest Therapeutics to Showcase Innovations at Key Conference
- Travere Therapeutics Announces Key Upcoming Investor Conferences
- Tesla Stock Faces Market Challenges Amid California Proposals
- Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
- Zoom Communications Turns a Profit with Impressive Q3 Earnings
- First Capital, Inc. Declares New Quarterly Dividend for Investors
- Columbia Financial Welcomes New COO Matthew Smith Amid Changes
- Universal Health Realty Income Trust Boosts Quarterly Dividend
- Amazon Strengthens AI Alliances with Major Investment in Anthropic
- Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
- Woodward's Q4 Earnings Highlights and Future Outlook for Investors
- Blue Bird's Q4 Earnings: Performance Review and Insights
- Central Garden & Pet: Analyzing Quarterly Earnings Results
- Central Garden & Pet Q4 Earnings Show Surprising Results
- Semtech's Q3 Earnings Report Shows Promising Growth
- LanzaTech Expands Board for Future Growth with Energy Expert
- Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
- Remitly to Showcase Innovations at Upcoming TMT Summit
- Dana Incorporates Leadership Change Amid Strategic Transformation
- Lexicon Pharmaceuticals Announces Upcoming December Investor Events
- Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
- NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
- ORIC Pharmaceuticals Enhances Visibility at December Conferences
- LanzaTech Welcomes Thierry Pilenko to Board of Directors
- Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
- EMP Metals Secures $3 Million Loan Agreement with Tembo
- Leslies Experiences Financial Challenges in Latest Earnings
- Dana Incorporates Strategic Changes to Boost Growth and Value
- Fluence Energy Delivers Impressive Q4 Results and Growth Insights
- StealthGas Reports Impressive Q3 Earnings Growth
- Analyzing PennantPark Floating Rate's Q4 Earnings Results
- Insights on Pennant Park Investment's Latest Earnings Report
- Central Garden & Pet Reports Improved Q4 Earnings Results
- Enanta Pharma Reports Strong Q4 Earnings Surprising Analysts
- Woodward's Impressive Earnings Surge: Insights and Guidance
- Blue Bird's Q4 Earnings Report: Insights and Analysis
- Overview of New Jersey Resources' Recent Earnings Report
- Central Garden & Pet Surprises Investors with Earnings Report
- Enanta Pharma Reports Promising Q4 Earnings Highlights
- Blue Bird Faces Earnings Challenge: A Detailed Overview